Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. - Wikidata - awgldk - TriplyDB

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

http://www.wikidata.org/entity/Q36376138

about

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids Technological considerations for genome-guided diagnosis and management of cancer Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma.Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control Current and Emerging Applications of Droplet Digital PCR in Oncology.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Integrating liquid biopsies into the management of cancer.An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy Detection of copy number alterations in cell-free tumor DNA from plasma.Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy.Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients

P2860

Q26739062-58340A53-CABC-44B1-B843-20722E76F3C8 Q28066706-0C80C422-C3B8-495E-9E36-8D9450C26EA9 Q28069755-E634EB32-26C0-4693-99ED-C46F2C9C7442 Q28073765-84E71C2F-7404-4185-875C-B24ADDFBBD85 Q30250097-309912FC-8ED9-4FC5-973D-06C391A72C41 Q37061376-896AC0D9-705D-45A2-A415-7159BA6BF1D6 Q37317518-F03142B0-36D4-42F2-9E47-04762D2E4A7D Q37641762-BD8CB7AF-7CB0-4B52-BCB3-5BA6680446E0 Q37694710-6F059CD3-9AFA-4485-868E-AD883D1F5A31 Q38374623-85F683D4-7356-48F4-9FAF-8AB13B6EC57A Q38726457-56A7A92C-9236-40EA-8160-8CC2CD51D2AC Q39157824-28019B4A-8264-42F1-945F-1A5234F2A3B4 Q39425159-8D7B2901-05C0-4148-ACAC-9463E8A123FC Q40492081-F0627FC3-2492-43AD-B884-661A0B0208EB Q41347759-6901DD63-57D2-4DDC-89B8-B60992204DCA Q41505555-CBA754FB-CC8E-49A2-BE15-78E524D9994D Q41624551-E7AD7B14-815A-41A1-9988-95A657ABAB5A Q42291714-B81A0D9F-5F3F-4937-A39D-3B4F5BCB42F4 Q45901388-9D505DB7-AFFD-4178-B750-5BDC1B8E1124 Q47120799-123CA5E5-3CDD-424B-9FB9-A8AA0DEC1ED8 Q47562193-EBA6063A-17FD-4DB5-AEFE-313CFCC33023 Q47602494-1E540934-190D-4764-8917-C556DF5AB925 Q48349892-E93B4057-9053-42B4-95FF-567F394F6749 Q48521971-4D8DECB4-C415-4C6D-910B-922235CD3758 Q49858111-D68BD7EF-A017-45D6-B10C-FFFFAD78B6A7 Q49924982-BD16D36D-7A03-480F-B24B-347F9CA28F65 Q52586328-F29FE722-FA73-484A-87D7-AC30605FE61F Q52739894-AC48DA34-8D31-45D1-910D-10EC88D0F6A2 Q53688649-CF5FF0C9-2FEC-49AB-9647-3288C5FC2F5A Q53702674-16052D7A-81A0-4165-8070-EB2A109883D0 Q58608805-59EB0A58-B493-407E-8DBF-2083920EBD95 Q58800609-21E765D8-3E81-4013-8EE5-0665D64E45FB Q58803568-0B8C537F-64D8-402B-AB71-4909F570545A

P2860

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

http://www.wikidata.org/entity/Q36376138

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@ast

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@en

type

label

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@ast

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@en

prefLabel

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@ast

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@en

P1433

Q36376138-691F6A29-DF31-4F0B-B92C-0076CE860AE3

P1476

Q36376138-AE5EF149-87C6-4808-B377-0F824FAF47FF

P2093

Q36376138-00D9F698-7C6E-4334-A035-E8563AEAA2E8

Q36376138-0BA3A115-4E94-470A-88DF-0F22FEC3041E

Q36376138-12D4E5FC-6C2E-4C5D-A307-1C39CD6E303B

Q36376138-27E3CF77-2B9A-44DE-B498-F2172E767D92

Q36376138-31459F29-67CF-4C09-AC0E-233619F91F12

Q36376138-405849A6-DDD2-4AEA-88DA-BA8378184033

Q36376138-4CDF6C8A-9498-4BD2-B52E-910ECCDAB9BF

Q36376138-5D665A53-DA41-4550-A7DE-86A151D29753

Q36376138-9399F202-8241-4D57-84D0-A642CAF229AB

Q36376138-A748AE65-D90A-4B03-93CB-BAB520A29D62

P2860

Q36376138-0A93255D-90C7-4144-A112-D5FF93B945B2

Q36376138-0D941D90-B213-4081-A1B1-10789747D8C4

Q36376138-0E3B93C6-4840-4B58-8B80-F2A3E7AFA5D4

Q36376138-1208387B-C223-4D3F-B685-D45A142940F7

Q36376138-146362DF-2CAC-4845-9099-544CE28A2E7E

Q36376138-1E04D9C4-3689-46B0-9B54-F77FD4A55A74

Q36376138-2260CE57-04F8-4EE8-A055-89F0AEB27BBD

Q36376138-22D50B2C-570F-4847-836B-0B4B4F8D6D4B

Q36376138-24619986-A975-4F0B-BE61-5F30BB28F484

Q36376138-328B51C1-E2F3-4A3A-87B5-F2EB968027B5

P2888

Q36376138-D04996C6-22E9-468C-AF10-0E79725B7C5B

P304

Q36376138-9142AE3A-B6B6-4E09-BE44-08CCB4DE8CA5

P31

Q36376138-062E2DAF-19E8-4C2E-A97E-0C363E41686C

P356

Q36376138-57AFC3F6-9663-4094-A902-5005514FB965

P407

Q36376138-C65A0B78-297A-4573-B078-008D19674A15

P478

Q36376138-E7146BA4-1180-4C8E-A8C9-2638DA767B71

P577

Q36376138-7FCA8E7C-A701-463F-93FB-B310963A942D

P5875

Q36376138-5CB39CDF-C51B-4E82-BB84-06BC4C8FE805

P698

Q36376138-4F4F8211-93F2-48C4-83FF-52FE53035B3C

P932

Q36376138-E8078DB3-5C89-469D-88B7-D2B1FD5B3C87

P356

P1433

Scientific Reports

P1476

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.

@en

P2093

Chigusa Morizane

http://www.w3.org/2001/XMLSchema#string

Eisaku Furukawa

http://www.w3.org/2001/XMLSchema#string

Erina Takai

http://www.w3.org/2001/XMLSchema#string

Hideki Ueno

http://www.w3.org/2001/XMLSchema#string

Hideyuki Hayashi

http://www.w3.org/2001/XMLSchema#string

Hiromi Nakamura

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nakagama

http://www.w3.org/2001/XMLSchema#string

Kazuaki Shimada

http://www.w3.org/2001/XMLSchema#string

Mamoru Kato

http://www.w3.org/2001/XMLSchema#string

Masami Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Mapping copy number variation by population-scale genome sequencing

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Paired-end mapping reveals extensive structural variation in the human genome

Fast and accurate short read alignment with Burrows-Wheeler transform

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

Liquid biopsies: genotyping circulating tumor DNA

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.

P2888

P304

18425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP18425

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287202695

http://www.w3.org/2001/XMLSchema#string

P698

26669280

http://www.w3.org/2001/XMLSchema#string

P932

4680882

http://www.w3.org/2001/XMLSchema#string